Ewe, iibhedi zonyango lokukhanya okubomvu (RLT) zihlala zithathwa njengezikhuselekileyo xa zisetyenziswa ngokuchanekileyo kwaye zineziphumo ebezingalindelekanga ezincinci. Nangona kunjalo, ukhuseleko luxhomekeke kwizinto ezifana nomgangatho wesixhobo, ixesha lokuvezwa kunye neemeko zempilo zomntu ngamnye. Nantsi inkcazelo eneenkcukacha:
Izinto zokhuseleko kwiibhedi zonyango lokukhanya okubomvu
Akukho misebe ye-UV
Ngokungafaniyo neebhedi zokuthambisa, iibhedi ze-RLT zisebenzisa ii-LED ezikhupha kuphela ukukhanya okubomvu (630–700 nm) kunye nokukhanya okukufutshane ne-infrared (800–900 nm). Ezi wavelength azinayo imitha ye-UV eyonakalisayo ye-DNA enxulunyaniswa nomhlaza wolusu.
Ayishushu kwaye ayihlaseli
Ukukhanya kuphantsi (LLLT), oko kuthetha ukuba akufudumezi okanye akutshisi ulusu. Kuvunyiwe yi-FDA ukunciphisa iintlungu kunye nonyango lolusu.
I-FDA iyivumile ukuba isetyenziswe kwezinye iindlela.
Ezinye izixhobo zivunyiwe ukunyanga iimeko ezifana neentlungu zemisipha namalungu, i-acne kunye nokulahleka kweenwele (umz. Joovv kunye neCelluma). Jonga ukuba i-FDA 510(k) clearance ayisebenzi.
Iziphumo ebezingalindelekanga ezincinci:
Okungaqhelekanga nokungathambi: ukuxinezeleka kwamehlo okwethutyana, ukoma okanye ukuba bomvu kancinci (kuphephe ukubonakala ngqo emehlweni - nxiba iiglasi zeglasi).
Iingozi ezinokubakho kunye neendlela zokuzikhusela:
Ukhuseleko lwamehlo:
Ukuvezwa ixesha elide kukukhanya okubomvu/okukufutshane ne-infrared (NIR) kunokubangela uxinzelelo lwe-retina. Sebenzisa izibuko zokukhusela rhoqo, ingakumbi kwiibhedi ezinamandla aphezulu.
Ubuthathaka bolusu:
Abantu abaneengxaki zokungaziva mnandi (umz. i-lupus okanye i-porphyria) okanye abasebenzisa amayeza okubangela ukuba umntu azive mnandi (umz. ii-antibiotics okanye i-Accutane) kufuneka baqale badibane nogqirha.
Ukusetyenziswa ngokugqithisileyo:
Okuninzi akusoloko kungcono. Iiseshoni ezigqithisileyo (umz. ngaphezulu kwemizuzu engama-20 ngosuku) zinokunciphisa iingenelo okanye zibangele ukurhawuzelelwa. Namathela kwizikhokelo zomenzi.
Iingxaki ze-thyroid:
Ukukhanya kwe-NIR kunokuchaphazela ukusebenza kwe-thyroid kwabanye abantu. Abo bane-hyperthyroidism kufuneka bajonge iimpawu zabo.
Ukukhulelwa:
Kukho uphando oluncinci. Njengesilumkiso, abafazi abakhulelweyo badla ngokucetyiswa ukuba baphephe unyango lokukhanya okubomvu komzimba wonke (i-RLT).
Ngubani omele aphephe iibhedi zonyango lokukhanya okubomvu?
Abantu abanomhlaza wolusu osebenzayo (kukho umngcipheko wethiyori wokuvuselela iiseli ezinobungozi).
Abo basebenzisa amayeza abangela ukuba umntu azive ekhululekile (umz. i-tetracyclines okanye i-retinoids).
Abantu abanesifo sokuwa (izibane ezikhanyayo zinokubangela ukuxhuzula kwiimeko ezingaqhelekanga).
Indlela yokusebenzisa ngokukhuselekileyo:
Khetha isixhobo esithembekileyo.
Khetha iimveliso ezivunyiweyo yi-FDA okanye ezivavanyiweyo ngokwezonyango (umz. iMerican). Ziphephe iimodeli ezingabizi kakhulu nezingenasiqinisekiso.
Landela izikhokelo zexesha/zomgama.
Iseshoni eqhelekileyo ithatha imizuzu eli-10 ukuya kwengama-20 kumgama wee-intshi ezi-6 ukuya kwezili-12 ukusuka ebhedini, izihlandlo ezi-3 ukuya kwezi-5 ngeveki.
Khusela amehlo akho:
Nxiba izibuko ezibomvu okanye ezingacacanga ezenzelwe i-RLT.
Uvavanyo lwepetshi kuqala.
Zama indawo encinci ukujonga ukuba ulusu lusabela njani.
Isivumelwano sesayensi:
Uphononongo luka-2023 kwi-Photobiomodulation, Photomedicine, kunye neLaser Surgery luqinisekisile ukuba i-RLT ikhuselekile kubasebenzisi abaninzi xa kulandelwa imigaqo.
Akukho mingcipheko yexesha elide efunyenweyo kwiminyaka emininzi isetyenziswa, kodwa uphando luyaqhubeka.
Okukwintsusa:
Iibhedi zonyango olubomvu azinabungozi kangako kubantu abaninzi, kodwa kufuneka udibane nogqirha ukuba uneengxaki ezithile zempilo. Namathela kwizixhobo ezisemgangathweni ophezulu kunye nezikhokelo ezifanelekileyo zokusetyenziswa.